Melanoma is the third most common cancer in Australia for both women and men.
Melanoma begins in cells known as melanocytes. The main cause of melanoma is exposure to ultraviolet (UV) radiation. The risk of developing melanoma grows with the amount of UV exposure, especially each time you experience sunburn. It can be years and even decades before any signs of melanoma begins so it is important for all ages and all skin types to reduce UV exposure.
Award winners! Shaping Australia Awards at Parliament House The Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) is undertaking world leading research into… Read More »Award winners! Shaping Australia Awards at Parliament House
A Test match against UV – skin cancer in cricketers. Australasia has the highest rate of skin cancer in the world. This is largely due… Read More »A Test match against UV – skin cancer in cricketers.
The 2025 Spot on Award for Dedication to Changing Australia’s Skin Cancer Landscape Congratulations to Professor Richard Scolyer AO who was awarded the Spot on… Read More »Spot on Award 2025
Ellie’s Story After her mum, Andeau, was diagnosed with mucosal melanoma in August 2023, Ellie and her auntie became Andeau’s devoted carers. Tragically, just ten months… Read More »Ellie’s Story
QIMR Berghofer has unveiled the next-generation of its world-leading melanoma risk prediction calculator to better help Australians take action against one of the country’s most… Read More »Melanoma risk calculator
10 years, 12 recommendations… what happened? In 2015, the Australian Parliament conducted the Skin Cancer in Australia: Our National Cancer inquiry, outlining twelve recommendations on… Read More »Skin Cancer Scorecard
MSCAN is proud to be part of the melanoma research led by QIMR Berghofer: testing whether receiving personalised genetic risk information can improve screening adherence… Read More »Q-Inform Trial
The bigger picture: Balancing innovation and evidence in the fight against melanoma This article has been republished from Monash Lens, featuring Victoria Mar, Professor, School… Read More »Balancing innovation and evidence in the fight against melanoma
CAR T cell therapy is one of the most exciting innovations in cancer care today. It uses a patient’s own immune cells—T cells—reprogrammed in a… Read More »Help shape the future of CAR T-cell therapy
The recent Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) Community & Consumer forum in February 2025 provided an opportunity to share the… Read More »Early detection with 3d imaging